You are in: eMedicine Specialties > Radiology > Cardiac
|
Cardiac Tumors Last Updated: February 21, 2007 |
|
| Synonyms and related keywords: cardiac neoplasms, primary cardiac tumors, secondary cardiac tumors, pericardial tumors, pericardial neoplasms, cardiac masses, pericardial masses, cardiac pseudotumors, heart tumors, heart neoplasms
|
|   |
AUTHOR INFORMATION
| Section 1 of 12  |
|
| Author: Julia Gates, MD, Consulting Staff and Assistant Residency Program Director, Department of Radiology, Baystate Medical Center Coauthor(s): George G Hartnell, MD, Professor of Radiology, Tufts University School of Medicine, Director of Cardiovascular and Interventional Radiology, Department of Radiology, Baystate Medical Center |
| Julia Gates, MD, is a member of the following medical societies:
Alpha Omega Alpha,
American Heart Association,
American Roentgen Ray Society,
Association of University Radiologists,
Massachusetts Medical Society,
Radiological Society of North America, and
Society of Cardiovascular and Interventional Radiology |
| Editor(s): Justin D Pearlman, MD, ME, PhD, MA, Director of Dartmouth Advanced Imaging Center, Professor of Medicine, Professor of Radiology, Adjunct Professor, Thayer Bioengineering and Computer Science, Dartmouth-Hitchcock Medical Center; Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand;
John D Newell, Jr, MD, FACR, FCCP, FASER, Co-Director of Thoracic Imaging, UCDHSC; Director of Lung Imaging Center, Professor of Radiology and Professor of Medicine, Department of Radiology, University of Colorado Health Sciences Center, National Jewish Medical and Research Center; Univ. Colorado Hospital;
Robert M Krasny, MD, Consulting Staff, Department of Radiology, The Angeles Clinic and Research Institute;
and Eugene C Lin, MD, Consulting Staff, Department of Radiology, Virginia Mason Medical Center |
Disclosure
|   |
INTRODUCTION
| Section 2 of 12  |
|
Background: Cardiac neoplasms may be primary or secondary, they may be related to the heart muscle or the pericardium, or they may occur by means of direct extension of primary tumors or by means of metastases from adjacent structures.
The presence of a cardiac tumor upon clinical examination and electrocardiography was first documented in 1934. Until that time, cardiac tumors were identified postmortem (Majano-Lainez, 1997). Angiography first was used to demonstrate a cardiac tumor within a chamber in 1951 (Majano-Lainez, 1997).
In general, primary cardiac tumors are of mesothelial or epithelial origin. Tumors include myxoma (see Images 1-13), fibroma, lipoma (see Image 14), rhabdomyoma, plasma cell granuloma, sarcoma, lymphoma (see Image 15), thymoma, hemangiopericytoma (see Images 16-19), fibroelastoma (see Images 20-21), angioma, hemangioma, angiomyolipoma/hamartoma, lymphangioma, and mycosis fungoides (Waller, 1989; Inoue, 2000; Gosalbez, 1999; Nakamura, 1987; Shapiro, 2001; Kemp, 1996; Grenadier, 1989; Tsai, 1997; Pasaoglu, 1991; Roberts, 1968).
Endodermal tumors also can be found. For example, atrioventricular (AV) nodal tumors may contain neuroendocrine cells, and thus they may be of endodermal origin, representing the so-called polycystic tumor of the AV node or congenital endodermal heterotopia of the AV node (Fine, 1987; Linder, 1984). Cardiac paragangliomas also have been described. Patients with these tumors present with hypertension and elevated urinary catecholamine levels (Johnson, 1985; Conti, 1986; Cane, 1996). The tumors tend to be left sided. Intracardiac pheochromocytomas also occur (Fitzgerald, 1995; Chang, 1991).
Myxomas usually are found in the left heart, but they do occur, less often, on the right (Symbas, 1976). Myxomas tend to be solitary and occur more often in women than in men. They are characteristically attached to the interatrial septum adjacent to the edge of the fossa ovalis in approximately 85% of patients (Schvartzman, 2000). Myxomas can invade the interatrial septum and the opposite atrium (Peachell, 1998). Tumors may be pedunculated (see Images 10-13) or polypoid (see Images 3-5) (Schvartzman, 2000).
Firm, oval masses are associated with dyspnea and show small vessels, tortuous vascularity, hemorrhage, and fibrosis. Soft papillary tumors tend be associated with neurologic symptoms and brain infarcts (Shimono, 1995). Almost one half may have surface thrombus, and almost one half may have fibrosis (Burke, 1993). Patients with left-heart myxomas may present with mitral valve obstruction (see Images 1-2 and Images 10-13) or features suggesting subacute bacterial endocarditis. Patients with right-heart myxomas may present with tricuspid valve disease, pulmonary embolism, or pulmonary hypertension (Symbas, 1976; Seemann, 1996).
Primary cardiac sarcomas encompass a broad spectrum of tumors that includes angiosarcoma (see Image 22), osteosarcoma, fibrosarcoma, malignant fibrous histiocytoma, leiomyosarcoma (see Images 23-24), myxosarcoma, synovial sarcoma, neurofibrosarcoma, lymphosarcoma, reticulum cell sarcoma, and undifferentiated sarcoma (Ohtahara, 1996; Dan, 1997; Lim, 1998; Seal, 1997; Fang, 1996; Lo, 1998; Davis, 1997; Kojima, 1999; Roberts, 1968; Burke, 1992; Araoz, 1999). Angiosarcomas tend to be located in the right heart (see Image 22), and osteosarcomas tend to be found in the left heart (Burke, 1992; Araoz, 1999). Primary cardiac liposarcoma has been reported; it is extremely rare and part of the differential diagnosis of a mass with fat signal intensity on MRIs. Most liposarcomas involving the heart either arise from the pericardial or are metastatic. All are rare.
Patients have been aged 1-75 years at presentation and may present with symptoms secondary to distal metastases (Burke, 1992; Shapiro, 1999; Romero-Menor, 1995; Colon, 1995). Osteosarcomas tend to calcify and are usually found in the left atrium (Araoz, 1999). Angiosarcomas are the most common primary cardiac malignant tumor, and leiomyosarcomas are the second most common malignant primary tumors of the heart. Leiomyosarcoma frequently invades the mitral valve and pulmonary veins, and it frequently involves the left atrium (Araoz, 1999). Other common sarcomas include rhabdomyosarcomas and fibrosarcomas. Fibrosarcoma is frequently necrotic and favors the left atrium (Araoz, 1999).
Metastatic disease may result from contiguous extension, lymphangitic spread, or hematogenous spread (Kapoor, 1986). Metastatic cardiac tumors are frequently bronchogenic carcinomas (see Images 25-26), breast carcinomas, lymphomas, leukemias, carcinoid tumors, or melanomas (McAdams, 1989; Roberts, 1968; Burn, 1999). Metastatic cervical carcinoma has been reported (Cutrone, 1995). Metastases to the heart tend to involve the myocardium rather than the valves and endocardium (Schvartzman, 2000). Alternatively, contiguous extension of tumor may come from primary or metastatic disease. For example, metastases to the lung can invade the mediastinum by means of local extension, such as by a malignant thymoma (Zissin, 1999; Korobkin, 1989). Liver cancer, such as hepatocellular carcinoma, can extend cephalad via the inferior vena cava into the heart (Wigmore, 1999).
Other abdominal tumors can affect the heart; extension of tumor thrombus via the inferior vena cava into the right atrium is a well-recognized complication of advanced renal cell carcinoma (see Image 27), and it also can occur with cervical carcinoma and renal angiomyolipomas (Ogawa, 1999; Vargas-Barron, 1990; Rothenberg, 1986). Benign uterine leiomyomatosis also can affect the heart intravenously (Steinmetz, 1996; Okamoto, 1994; Kaszar-Seibert, 1988). Germ cell tumors (eg, testicular teratomas) and embryonal cell carcinomas can metastasize to the heart, as can choriocarcinomas (Pickuth, 1992; Paule, 1991; Chandrashekar, 1995). Thyroid metastases have been seen (Haggerty, 1990). Musculoskeletal tumors, such as hemangiopericytomas, also can metastasize and grow in the heart (Sato, 1995).
Primary pericardial tumors include malignant spindle tumor, localized fibrous tumor (also called localized fibrous mesothelioma), pericardial cysts (see Images 28-30), liposarcoma, lipoma (see Image 31), and teratoma (Fukuda, 1989; el-Naggar, 1989; Watanabe, 1999; Andreani, 1998; Araoz, 1999; Romer, 1999; Doshi, 1998; Bitar, 1998). Cardiac angiosarcomas tend also to involve the pericardium secondarily and to produce hemorrhagic pericardial effusions (Kim, 1989).
Pericardial mesotheliomas frequently are associated with asbestos exposure. Most specimens have identifiable asbestos fibers, particularly crocidolite and amosite fibers, as well as chrysotile to a lesser extent (Morinaga, 1989). However, not all mesotheliomas arise in patients with a prior history of asbestos exposure (Watanabe, 1999). Lymphomas frequently are found in patients who are immunocompromised and frequently involve the pericardium (Araoz, 1999). Liposarcomas are rare tumors, they tend to be extracardiac, and they tend to form large infiltrating masses (Araoz, 1999).
Primary tumors of the cardiac valves and chordae are uncommon; however, when they do occur, most often, they are fibroelastomas (Graca, 1999; Di Mattia, 1999; Cesena, 1999; de Menezes, 1996). Fibroelastomas are small tumors that may be an incidental finding at autopsy (see Images 20-21). They can be mistaken for a valve vegetation. Lipomatous tumors of the heart valves also have been described (Benvenuti, 1996).
Primary cardiac tumors appearing in childhood include rhabdomyomas, intrapericardial teratomas, myxomas, fibromas, hemangiomas, mesotheliomas, multicystic hamartomas, epicardial lipomas, and rhabdomyosarcomas; some tumors cannot be identified pathologically (de Bustamante, 2000; Sievers, 2000; Sallee, 1999; Beghetti, 1997). Rhabdomyomas are the most common pediatric cardiac tumor, and most children with rhabdomyomas have tuberous sclerosis (Sallee, 1999). Rhabdomyomas can affect all 4 cardiac chambers (Takatoh, 1988). Rhabdomyomas frequently resolve spontaneously (Shapiro, 2001). Most primary pediatric tumors are diagnosed in the first year of life (Sallee, 1999). Rhabdomyosarcoma is the most common pediatric malignant cardiac primary neoplasm. Compared with other primary cardiac sarcomas, rhabdomyosarcomas are more likely to involve the valves (Araoz, 1999).
Primary pediatric cardiac tumors present with murmurs and arrhythmias (Sallee, 1999). Intrapericardial tumors can cause airway compression and subsequent dyspnea. In utero, fetuses can present with abnormal sonogram findings (Czechowski, 2000). The tumors can cause conduction abnormalities. Conduction abnormalities can be evaluated by electrophysiology testing and may be amenable to radiofrequency ablation (Sallee, 1999).
Some cardiac masses may not be tumors. Non-neoplasms or pseudotumors include thrombus or variants of cardiac anatomy, eg, prominent pulmonary vein orifice (see Images 32-33), right atrial Chiari network or crista terminalis (see Images 34-35), valvular vegetation, thrombus within a left ventricular aneurysm, lipomatous hypertrophy of the interatrial septum (see Image 36), rheumatoid nodule, pulmonary collapse, ruptured chordae tendineae, intracardiac varices, tumors outside the heart and pericardium (can resemble a cardiac mass, eg, phrenic nerve tumor), and anatomic structures, such as hiatal hernia (see Image 37; Kindman, 1998; Webber, 1995; Plehn, 1988; Atalay, 1995; Harrity, 1995; Ewy, 1995). Frequency:
- In the US: The frequency of cardiac tumors is dependent on the frequency of autopsy and the patient population being evaluated (see also Age).
- Benign primary tumors are more frequent than primary malignant tumors. In autopsy series, the cumulative prevalence of primary cardiac tumors is 0.001-0.3% (Urba, 1986; McAllister, 1979).
Overall, myxomas account for approximately 30% of all primary cardiac neoplasms. Of atrial myxomas, 90% occur on the left and 90% are solitary (Shapiro, 2001). Angiosarcomas account for 33% of all malignant primary cardiac neoplasms, and myxomas account for approximately 50% of all benign primary cardiac neoplasms (Shapiro, 2001). Lipomas are the second most common benign cardiac tumor and account for approximately 10% of all cardiac neoplasms (Hoffmann, 1998; Vanderheyden, 1998). The most common intracardiac mass is thrombus (Schvartzman, 2000).
- Secondary tumors are accepted to be more common than primary tumors by a factor of 20-30.
- Metastatic tumors to the heart and pericardium are more common than primary neoplasms and occur in as many as 1.5% of patients with malignancies (Schvartzman, 2000). The most common sources of metastatic tumors are as follows (in approximate order of frequency): bronchogenic carcinoma of the breast; lymphoma; leukemia; esophagus; uterus; melanoma; stomach; sarcomas; germ cell tumors; and tumors of the oral/tongue, colon/rectum, kidney, thyroid, larynx, urinary bladder, hepatobiliary system, prostate, pancreas, and ovary (Roberts, 1998).
- Internationally: The incidence is identical to that in the United States.
Mortality/Morbidity:
- Angiosarcomas have a high mortality rate, and most patients do not survive beyond 6 months of the diagnosis (Shapiro, 2001).
- Mortality rates in patients with other malignant tumors also are high, especially in those with metastases, which tend to involve the heart late in the course of malignant disease.
- Benign tumors can usually be resected and have a good prognosis.
Race: No data about racial factors are available.
Sex:
- Cardiac myxomas tend to occur more often in women than in men (Shapiro, 2001).
- Cardiac lipomas have no sex predilection (Schvartzman, 2000).
- Rhabdomyosarcomas and angiosarcomas are more common in males than in females (Shapiro, 2001).
Age: Patients with primary cardiac sarcomas have presented at age 1-75 years (Burke, 1992). Cardiac lipomas occur in patients of any age (Schvartzman, 2000).
- Pediatric tumors: Most primary pediatric tumors are diagnosed within the first year of life (Sallee, 1999).
Among pediatric patients, primary cardiac neoplasms include rhabdomyoma (78%), fibroma (11%), pericardial teratoma (2%), epicardial lipoma (2%), multicystic hamartoma (2%), and unspecified (5%; Beghetti, 1997).
In children aged 15 years or younger, the most common benign primary cardiac tumors are as follows: rhabdomyoma (the most common benign primary tumor in those <1 y of age and associated with tuberose sclerosis in 30-50%), fibroma, hemangioma, and teratoma (Roberts, 1998).
In children aged 15 years or younger, the most common malignant primary cardiac tumors are as follows: rhabdomyosarcoma fibrous histiocytoma, angiosarcoma, fibrosarcoma, and myxoid sarcoma (Roberts, 1998).
- Adult tumors: Angiosarcomas tend to be found in patients aged 20-50 years (Kim, 1989; Mader, 1997). About 70% of myxomas occur in middle-aged patients (Schvartzman, 2000), usually those aged 50-70 years (Shapiro, 2001).
In adults, the most common benign primary cardiac tumors are as follows (in approximate order of frequency): myxoma, (>50%, fibroma, hemangioma, granular cell tumor, lipoma, paraganglioma, hamartoma, histiocytoma, and hemangioendothelioma (Roberts, 1998).
In adults, the most common malignant primary cardiac tumors are as follows (in approximate order of frequency): angiosarcoma, fibrous histiocytoma, leiomyosarcoma, osteosarcoma, fibrosarcoma, myxoid sarcoma, rhabdomyosarcoma, and liposarcoma (Roberts, 1998).
Clinical Details: Patients with left heart disease may present with mitral valve obstruction or apparent subacute bacterial endocarditis. Patients with right heart disease may present with tricuspid valve disease, pulmonary embolism, or hypertension (Symbas, 1976).
Atrial myxomas can cause breathlessness, fever, weight loss, syncope, hemoptysis, peripheral emboli, and sudden death (Shapiro, 2001).
Angiosarcomas frequently involve the right heart and result in right-sided heart failure. Patients may also present with cardiac tamponade secondary to bloody pericardial effusions or with pleuritic chest pain (Shapiro, 2001; Schvartzman, 2000; Kim, 1989).
Intrapericardial masses can cause dyspnea as a result of compression of airways (Doshi, 1998; Sievers, 2000).
Patient with cardiac fibromas may present with congestive heart failure, arrhythmias, sudden death, cyanosis, or chest pain, although one third of patients may be asymptomatic (Burke, 1994; Parmley, 1998).
Patients with intracardiac pheochromocytomas may present with chest pain, palpitations, and flushing (Fitzgerald, 1995). Catecholamine release can cause irregular heartbeats, which can be detected by the patient as palpitations. Blood pressure can rise with an increased pulse rate, resulting in more work for the heart.
Lipomatous hypertrophy of the interatrial septum frequently is found in people with obesity (Shapiro, 2001) (see Image 36).
Most children with rhabdomyomas also have tuberous sclerosis, which is associated with adenoma sebaceum, seizures, and mental retardation. Preferred Examination: Initially, intracardiac tumors are often best evaluated by using echocardiography. Differentiation of left atrial masses from thrombus may best be achieved by using transesophageal echocardiography. Owing to a larger field of view with a better opportunity to assess contiguous extracardiac involvement or the presence of metastatic disease, MRI, magnetic resonance angiography (MRA), and CT are preferred over echocardiography for less-straightforward cases or for cases in which acoustic access is restricted. Limitations of Techniques: Chest radiography may show the effects of intracardiac obstruction with features of pulmonary edema (see Images 1-2), but otherwise, they may contribute little. Echocardiography is easily accessible, but it is limited by restricted acoustic access. CT scanning is accurate, but it requires radiation and contrast material. In suitable patients, MRI has the fewest limitations provided that the patient can remain motionless during the examination.
|   |
DIFFERENTIALS
| Section 3 of 12  |
|
Chondrosarcoma Leiomyoma, Uterus (Fibroid) Liposarcoma, Soft Tissue Mesothelioma, Malignant Osteosarcoma, Variants Pheochromocytoma Renal Cell Carcinoma
Other Problems to be Considered:
Primary cardiac tumors - Myxoma, fibroma, lipoma, rhabdomyoma, plasma cell granuloma, sarcoma, lymphoma, thymoma, hemangiopericytoma, fibroelastoma, mycosis fungoides, hamartoma/angiomyolipoma, hemangioma, angioma, lymphangioma, and pheochromocytoma
Primary cardiac sarcomas - Angiosarcoma, osteosarcoma, fibrosarcoma, malignant fibrous histiocytoma, leiomyosarcoma, myxosarcoma, synovial sarcoma, neurofibrosarcoma, liposarcoma, lymphosarcoma, reticulum cell sarcoma, and undifferentiated sarcoma
Metastatic tumors - Bronchogenic carcinoma, breast carcinoma, lymphoma, leukemia, carcinoid tumor, melanoma, cervical carcinoma, and germ cell tumors
Primary pediatric cardiac tumors - Rhabdomyoma, intrapericardial teratoma, myxoma, fibroma, hemangioma, mesothelioma, multicystic hamartoma, epicardial lipoma, and rhabdomyosarcoma
Pericardial tumors - Malignant spindle tumor, localized fibrous tumor (also termed localized fibrous mesothelioma), pericardial cyst, direct extension of primary cardiac tumors, or lung cancer
|   |
RADIOGRAPH
| Section 4 of 12  |
|
Findings: Plain radiography is not an effective method for screening for cardiac neoplasms or evaluating the extent of tumor.
- Cardiac myxomas may be calcified, and hence, they may be visible on lateral chest radiographs.
- Left atrial enlargement may be noted; this may result from mitral valve obstruction (see Images 1-2).
- Disease that expands the cardiac silhouette, by either bulk or secondary effusion, may be suggestive of pericardial involvement.
Degree of Confidence: The degree of confidence is limited. Plain radiographic changes in cardiac tumors are nonspecific. |
|
Patient Education
|
|
Click here for patient education.
|
|
|
|
|
|   |
CT SCAN
| Section 5 of 12  |
|
Findings: By virtue of its larger field of view, CT scanning is better than echocardiography in many situations in which mediastinal involvement or restricted acoustic access is suspected. Both the heart and contiguous structures can be assessed.
- Cardiac function and the effects of a tumor on function can be evaluated using ECG-gated multiring detector spiral scanners or electron-beam scanners. Such functional imaging is on par with functional MRI.
- These techniques also can be used to detect the motion of a pedunculated tumor, such as an atrial myxoma.
- Tumors that calcify, eg, myxomas, can also be imaged by using CT scans, with excellent depiction of calcific attenuating areas.
- Tumor tissue tends to have an attenuation of approximately 40-100 HU (Schvartzman, 2000). Cardiac or pericardial lipomas are identified easily by low attenuation (-100 HU) and look similar to the fat of the mediastinum (Mousseaux, 1996) (see Image 31).
- Angiosarcomas frequently appear as a right atrial mass with an accompanying hemopericardium (Schvartzman, 2000) (see Image 22).
Degree of Confidence: The degree of confidence is high for detecting tumors on contrast-enhanced CT scanning. Tissue characterization is limited. ECG gating improves image quality and precision.
|   |
MRI
| Section 6 of 12  |
|
Findings: Both MRI and MRA are superior to echocardiography in detecting or excluding cardiac tumors, the precise location of cardiac tumors (ie, paracardiac, mural, or intracavitary), the extent of disease, the presence of effusions, and the presence of metastases (Link, 1995). Other effects and complications of tumors are demonstrated well. Contrast-enhanced MRI may define the extent of the tumor, but it is limited in discerning benign from malignant disease. MRI has advantages over CT, because intravenous contrast material is not required for imaging.
- Extracardiac disease is demonstrated well, as is the cardiac morphology.
- Cardiac contractility can be evaluated (Carrol, 1996).
- MRI may be better than CT at providing superior depiction of tumor morphology via soft-tissue contrast resolution (Schvartzman, 2000).
- Effects of the disease on cardiac function can be assessed by using MRI/MRA via cine and tagging techniques.
- Contrast-enhanced MRI can be used to differentiate areas of slow flow from solid material (ie, thrombus or tumor).
- Based on signal-intensity characteristics, an estimate of the tissue type may be possible. Fatty masses demonstrate high signal intensity on T1-weighted spin-echo images (see Image 14) and medium signal intensity on T2-weighted spin-echo images.
- Lipomatous hypertrophy of the interatrial septum (LHIAS) (see Image 36) is a transformation of tissue rather than a neoplasm, per se. LHIAS demonstrates high signal intensity on T1-weighted images and can extend to the free wall.
- Myxomas tend to have low signal intensity on breath-hold cine images, and they are visually conspicuous against surrounding bright (hyperintense) blood (see Images 3-4, Image 8). Similarly, turbo short-tau inversion recovery images demonstrate a hyperintense tumor enveloped by hypointense blood within the atrium (Kemp, 1996) (see Image 7). However, myxomas have variable amounts of calcification and fibrous and myxomatous tissue (which is bright on T2-weighted images). Water-rich myxomatous tissue tends to have signal intensity higher than that of normal myocardium on T2-weighted images (Schvartzman, 2000).
- Angiosarcomas often have high signal intensity on T1-weighted images (Araoz, 1999).
Gadolinium-based contrast agents (gadopentetate dimeglumine [Magnevist], gadobenate dimeglumine [MultiHance], gadodiamide [Omniscan], gadoversetamide [OptiMARK], gadoteridol [ProHance]) have recently been linked to the development of nephrogenic systemic fibrosis (NSF) or nephrogenic fibrosing dermopathy (NFD). For more information, see the eMedicine topic Nephrogenic Fibrosing Dermopathy. The disease has occurred in patients with moderate to end-stage renal disease after being given a gadolinium-based contrast agent to enhance MRI or MRA scans. As of late December 2006, the FDA had received reports of 90 such cases. Worldwide, over 200 cases have been reported, according to the FDA. NSF/NFD is a debilitating and sometimes fatal disease. Characteristics include red or dark patches on the skin; burning, itching, swelling, hardening, and tightening of the skin; yellow spots on the whites of the eyes; joint stiffness with trouble moving or
straightening the arms, hands, legs, or feet; pain deep in the hip bones or ribs; and muscle weakness. For more information, see the FDA Public Health Advisory or Medscape. Degree of Confidence: MRI probably offers the most accurate noninvasive test in patients who can hold their breath. Prominence of the crista terminalis or Chiari network and juxtacardiac masses can be mistaken for tumors (see Images 32-37). False Positives/Negatives: Few false findings occur. Errors most frequently result from patient movement or interpreter inexperience (eg, misinterpretation of pseudotumors).
|   |
ULTRASOUND
| Section 7 of 12  |
|
Findings: Unlike CT or MRI, echocardiography is somewhat operator dependent, and it has a more limited field of view. Areas behind the sternum, ribs, or lung cannot be visualized adequately, and acoustic windows limit the structures imaged on any single plane or view. The benefit of echocardiography is its portability and ease of use for a first-peek approach to cardiac pathology.
In many patients, especially those with myxomas, echocardiography may be all that is required to make the diagnosis and stage the tumor. In patients with poor-quality transthoracic echocardiograms, transesophageal echocardiography usually provides better images, especially of masses in or adjacent to the left atrium (see Images 12-13).
- Characteristic findings on M-mode and 2-dimensional echocardiography of the most common primary cardiac tumor (ie, left atrial myxoma) demonstrate an echogenic mass in the left atrium during ventricular systole, which is seen prolapsing through the mitral valve during diastole (see Images 9-13).
- The mass may be mobile or relatively sessile.
- Myxomas may demonstrate variable echogenicity and can cause atrial enlargement.
- Other tumors may invade the myocardium or project into the affected cavities (see Image 27). Often, pericardial effusion is associated with malignant tumors (see Image 15).
- Prenatal ultrasonography can identify intracardiac masses and brain lesions of tuberous sclerosis and intrapericardial tumors, such as teratoma (Czechowski, 2000; de Bustamante, 2000).
Degree of Confidence: Ultrasonographic findings are accurate for identifying tumors inside cardiac chambers provided acoustic access is adequate. Ultrasonography is less helpful if acoustic access is poor or if tumors extend outside the heart or into the great vessels. Although it is more invasive, transesophageal echo imaging is best for imaging left atrial and left ventricular tumors. False Positives/Negatives: Prominence of the crista terminalis or Chiari network juxtacardiac masses (eg, hiatus hernia) may create false findings (see Image 37).
|   |
NUCLEAR MEDICINE
| Section 8 of 12  |
|
Findings: Pheochromocytomas may be imaged by using metaiodobenzylguanidine uptake studies; otherwise, the use of nuclear medicine studies is limited.
|   |
ANGIOGRAPHY
| Section 9 of 12  |
|
Findings: The need for angiography is limited. Tumor vascularity may be seen with selective angiography (see Image 19). Generally, angiography is required only if information concerning coronary artery anatomy is required or if percutaneous intervention is planned.
Neovascularity of myxomas may be seen on selective angiography (Centofanti, 1999; Sawaya, 2001).
|   |
INTERVENTION
| Section 10 of 12  |
|
Intervention: Benign tumors can usually be resected and have a good prognosis.
Lymphoma tends to be responsive to chemotherapy (Araoz, 1999). Rhabdomyosarcomas also may be treated with chemotherapy. Pediatric rhabdomyomas are treated conservatively because many resolve spontaneously (Shapiro, 2001). Angiosarcomas have a poor prognosis and are not responsive to chemotherapy. Most patients die within 6 months of the diagnosis (Shapiro, 2001). In extreme cases, selective embolization or chemoembolization may help relieve the symptoms (see Image 19).
Outflow obstructions can be treated with stenting (Balkin, 1997).
Benign cysts can safely be drained under echocardiographic or CT guidance with a high expectation of success (see Images 28-30).
|   |
PICTURES
| Section 11 of 12  |
|
|   |
BIBLIOGRAPHY
| Section 12 of 12 |
|
-
Andreani SM, Tavecchio L, Giardini R, Bedini AV: Extrapericardial solitary fibrous tumour of the pericardium. Eur J Cardiothorac Surg 1998 Jul; 14(1): 98-100[Medline].
-
Araoz PA, Eklund HE, Welch TJ, Breen JF: CT and MR imaging of primary cardiac malignancies. Radiographics 1999 Nov-Dec; 19(6): 1421-34[Medline].
-
Atalay S, Imamoglu A, Uluoglu O, Ikizler C: Critical tricuspid regurgitation secondary to ruptured chordae tendineae mimicking a mass on the tricuspid valve in a newborn. Pediatr Cardiol 1995 May-Jun; 16(3): 133-6[Medline].
-
Balkin PW, Imoto EM: Treatment of malignant obstruction of the right ventricular outflow tract and pulmonary artery with metallic stents. AJR Am J Roentgenol 1997 Aug; 169(2): 439-40[Medline].
-
Beghetti M, Gow RM, Haney I, et al: Pediatric primary benign cardiac tumors: a 15-year review. Am Heart J 1997 Dec; 134(6): 1107-14[Medline].
-
Benvenuti LA, Mansur AJ, Lopes DO, Campos RV: Primary lipomatous tumors of the cardiac valves. South Med J 1996 Oct; 89(10): 1018-20[Medline].
-
Bitar FF, el-Zein C, Tawil A, et al: Intrapericardial teratoma in an adult: a rare presentation. Med Pediatr Oncol 1998 Apr; 30(4): 249-51[Medline].
-
Burke AP, Virmani R: Cardiac myxoma. A clinicopathologic study. Am J Clin Pathol 1993 Dec; 100(6): 671-80[Medline].
-
Burke AP, Cowan D, Virmani R: Primary sarcomas of the heart. Cancer 1992 Jan 15; 69(2): 387-95[Medline].
-
Burke AP, Rosado-de-Christenson M, Templeton PA, Virmani R: Cardiac fibroma: clinicopathologic correlates and surgical treatment. J Thorac Cardiovasc Surg 1994 Nov; 108(5): 862-70[Medline].
-
Burn PR, Chinn R, King DM: Right atrial metastatic melanoma detected by dynamic contrast enhanced spiral CT. Br J Radiol 1999 Apr; 72(856): 395-6[Medline].
-
Cane ME, Berrizbeitia LD, Yang SS, et al: Paraganglioma of the interatrial septum. Ann Thorac Surg 1996 Jun; 61(6): 1845-7[Medline].
-
Carrol CL, Higgins CB, Caputo GR: Magnetic resonance imaging of acquired cardiac disease. Tex Heart Inst J 1996; 23(2): 144-54[Medline].
-
Centofanti P, Patane F, Barbato L, et al: Left atrial approach to big myxoma with angiographically visible neovascularity. Report of one case. J Cardiovasc Surg (Torino) 1999 Jun; 40(3): 391-3[Medline].
-
Cesena FH, Pereira AN, Dallan LA, et al: Papillary fibroelastoma of the mitral valve 12 years after mitral valve commissurotomy. South Med J 1999 Oct; 92(10): 1023-8[Medline].
-
Chandrashekar G: Choriocarcinoma presenting as intracardiac (intracavitary) tumour. Int J Cardiol 1995 Jun 30; 50(2): 197[Medline].
-
Chang CH, Lin PJ, Chang JP, et al: Intrapericardial pheochromocytoma. Ann Thorac Surg 1991 Apr; 51(4): 661-3[Medline].
-
Cohen IS, Raiker K: Atrial lipomatous hypertrophy: lipomatous atrial hypertrophy with significant involvement of the right atrial wall. J Am Soc Echocardiogr 1993 Jan-Feb; 6(1): 30-4[Medline].
-
Colon G, Quint DJ, Blaivas M, McGillicuddy J: Cardiac sarcoma metastatic to the brain. AJNR Am J Neuroradiol 1995 Sep; 16(8): 1739-41[Medline].
-
Conti VR, Saydjari R, Amparo EG: Paraganglioma of the heart. The value of magnetic resonance imaging in the preoperative evaluation. Chest 1986 Oct; 90(4): 604-6[Medline].
-
Cutrone JA, Georgiou D, Yospur LS, et al: Metastatic spread of cervical carcinoma to the right ventricle and pulmonary arteries: diagnosis by ultrafast computed tomography. Am J Card Imaging 1995 Oct; 9(4): 275-9[Medline].
-
Czechowski J, Langille EL, Varady E: Intracardiac tumour and brain lesions in tuberous sclerosis. A case report of antenatal diagnosis by ultrasonography. Acta Radiol 2000 Jul; 41(4): 371-4[Medline].
-
Dan S, Hodge AJ: Osteogenic sarcoma of the left atrium. Ann Thorac Surg 1997 Jun; 63(6): 1766-8[Medline].
-
Davis GK, Jones EL, Bonser RS, Roberts DH: Coronary arteriographic and pathological findings in a case of primary leiomyosarcoma of the heart. Int J Cardiol 1997 May 23; 59(3): 313-6[Medline].
-
de Bustamante TD, Azpeitia J, Miralles M, et al: Prenatal sonographic detection of pericardial teratoma. J Clin Ultrasound 2000 May; 28(4): 194-8[Medline].
-
de Menezes IC, Fragata J, Martins FM: Papillary fibroelastoma of the mitral valve in a 3-year-old child: case report. Pediatr Cardiol 1996 May-Jun; 17(3): 194-5[Medline].
-
Di Mattia DG, Assaghi A, Mangini A, et al: Mitral valve repair for anterior leaflet papillary fibroelastoma: two case descriptions and a literature review. Eur J Cardiothorac Surg 1999 Jan; 15(1): 103-7[Medline].
-
Doshi S, Halim M, Singh H, Patel R: Massive intrapericardial lipoma, a rare cause of breathlessness. Investigations and management. Int J Cardiol 1998 Sep 30; 66(2): 211-5[Medline].
-
el-Naggar AK, Ro JY, Ayala AG, et al: Localized fibrous tumor of the serosal cavities. Immunohistochemical, electron-microscopic, and flow-cytometric DNA study. Am J Clin Pathol 1989 Nov; 92(5): 561-5[Medline].
-
Ewy MF, Demmy TL, Perry MC, et al: Massive phrenic perineurioma mimicking an unresectable cardiac tumor. Ann Thorac Surg 1995 Jul; 60(1): 188-9[Medline].
-
Fang CY, Fu M, Chang JP, et al: Malignant fibrous histiocytoma of the left ventricle: a case report. Changgeng Yi Xue Za Zhi 1996 Jun; 19(2): 187-90[Medline].
-
Fine G, Raju U: Congenital polycystic tumor of the atrioventricular node (endodermal heterotopia, mesothelioma): a histogenetic appraisal with evidence for its endodermal origin. Hum Pathol 1987 Aug; 18(8): 791-5[Medline].
-
Fitzgerald PJ, Ports TA, Cheitlin MD, et al: Intracardiac pheochromocytoma with dual coronary blood supply: case report and literature review. Cardiovasc Surg 1995 Oct; 3(5): 557-61[Medline].
-
Fukuda T, Ishikawa H, Ohnishi Y, et al: Malignant spindle cell tumor of the pericardium. Evidence of sarcomatous mesothelioma with aberrant antigen expression. Acta Pathol Jpn 1989 Nov; 39(11): 750-4[Medline].
-
Gosalbez F, Miralles T, Cofino J, et al: Primary lymphomas of the heart in immunocompetent patients. Presentation of two cases with one 12 year survival. Analysis of surgical implications. Minerva Cardioangiol 1999 Mar; 47(3): 75-9[Medline].
-
Graca A, Nunes R, Costeira A, et al: Cardiac papillary fibroelastoma of a mitral valve chordae revealed by stroke. Rev Port Cardiol 1999 Oct; 18(10): 937-9[Medline].
-
Grenadier E, Margulis T, Palant A, et al: Huge cavernous hemangioma of the heart: a completely evaluated case report and review of the literature. Am Heart J 1989 Feb; 117(2): 479-81[Medline].
-
Haggerty MF, Murphy TM: Metastatic anaplastic thyroid carcinoma to the right ventricle of the heart. AJR Am J Roentgenol 1990 Nov; 155(5): 1136[Medline].
-
Harrity PJ, Tazelaar HD, Edwards WD, et al: Intracardiac varices of the right atrium: a case report and review of the literature. Int J Cardiol 1995 Feb; 48(2): 177-81[Medline].
-
Hoffmann U, Globits S, Frank H: Cardiac and paracardiac masses. Current opinion on diagnostic evaluation by magnetic resonance imaging. Eur Heart J 1998 Apr; 19(4): 553-63[Medline].
-
Inoue H, Shimokawa S, Iguro Y, et al: Involvement of the right atrium by malignant lymphoma as a cause of right cardiac failure: report of a case. Surg Today 2000; 30(4): 394-6[Medline].
-
Johnson TL, Shapiro B, Beierwaltes WH, et al: Cardiac paragangliomas. A clinicopathologic and immunohistochemical study of four cases. Am J Surg Pathol 1985 Nov; 9(11): 827-34[Medline].
-
Kapoor A: Clinical manifestations of neoplasia of the heart. In: Kapoor A, ed. Cancer of the Heart. New York: Springer-Verlag; 1986.
-
Kaszar-Seibert DJ, Gauvin GP, Rogoff PA, et al: Intracardiac extension of intravenous leiomyomatosis. Radiology 1988 Aug; 168(2): 409-10[Medline].
-
Kemp JL, Kessler RM, Raizada V, Williamson MR: Case report. MR and CT appearance of cardiac hemangioma. J Comput Assist Tomogr 1996 May-Jun; 20(3): 482-3[Medline].
-
Kim EE, Wall
|